Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation: An observational study

Journal of Cardiothoracic Surgery

Volumn 5, Issue 1, 2010, Pages

  Ege, Erdal ^a   Dereli, Yüksel ^b   Kurban, Sevil ^a   Sarigül, Ali ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; CREATINE KINASE MB; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE; TROPONIN I;

AGED; ARTICLE; BLOOD; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; CREATINE KINASE, MB FORM; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PYRROLES; TROPONIN I;

EID: 77955484717     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-5-60     Document Type: Article

References (24)

1. Chan AW, Bhatt DL, Chew DP, Reginelli J, Schneider JP, Topol EJ, Ellis SG. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation 2003, 107:1750-1756. 10.1161/01.CIR.0000060541.18923.E9, 12665489.
2. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996, 335:1001-1009. 10.1056/NEJM199610033351401, 8801446.
3. Etievent JP, Chocron S, Toubin G, Taberlet C, Alwan K, Clement F, Cordier A, Schipman N, Kantelip JP. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg 1995, 59:1192-1194. 10.1016/0003-4975(95)00129-9, 7733719.
4. Mueller C, Neumann FJ, Perruchoud AP, Zeller T, Buettner HJ. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention. Am J Med 2004, 117:897-902. 10.1016/j.amjmed.2004.06.043, 15629727.
5. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 2005, 26:2493-2519. 10.1093/eurheartj/ehi455, 16176941.
6. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004, 110:674-678. 10.1161/01.CIR.0000137828.06205.87, 15277322.
7. Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 2008, 136:1541-1548. 10.1016/j.jtcvs.2008.06.038, 19114204.
8. Pascual DA, Arribas JM, Tornel PL, Marín F, Oliver C, Ahumada M, Gomez-Plana J, Martínez P, Arcas R, Valdes M. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg 2006, 81:78-83. 10.1016/j.athoracsur.2005.07.038, 16368340.
9. Magovern JA, Moraca RJ, Bailey SH, Dean DA, Simpson KA, Maher TD, Benckart DH, Magovern GJ. Preoperative statin is associated with decreased operative mortality in high risk coronary artery bypass patients. J Cardiothorac Surg 2010, 5:8. 10.1186/1749-8090-5-8, 2841066, 20181268.
10. Flaker GC, Warnica JW, Sacks FM, Moyé LA, Davis BR, Rouleau JL, Webel RR, Pfeffer MA, Braunwald E. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol 1999, 34:106-112. 10.1016/S0735-1097(99)00145-X, 10399998.
11. Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002, 105:1446-1452. 10.1161/01.CIR.0000012530.68333.C8, 11914253.
12. Plenge JK, Hernandez TL, Weil KM, Poirier P, Grunwald GK, Marcovina SM, Eckel RH. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002, 106:1447-1452. 10.1161/01.CIR.0000029743.68247.31, 12234946.
13. Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem 2000, 37(Pt 6):764-769. 10.1258/0004563001900075, 11085620.
14. Garbarz E, Iung B, Lefevre G, Makita Y, Farah B, Michaud P, Graine H, Vahanian A. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 1999, 84:515-518. 10.1016/S0002-9149(99)00369-0, 10482147.
15. Brener SJ, Ellis SG, Schneider J, Topol EJ. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 2002, 23:869-876. 10.1053/euhj.2001.2976, 12042008.
16. Nallamothu BK, Bates ER. Periprocedural myocardial infarction and mortality: causality versus association. J Am Coll Cardiol 2003, 42:1412-1414. 10.1016/S0735-1097(03)01037-4, 14563584.
17. Kourliouros A, De Souza A, Roberts N, Marciniak A, Tsiouris A, Valencia O, Camm J, Jahangiri M. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg 2008, 85:1515-1520. 10.1016/j.athoracsur.2008.01.040, 18442529.
18. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001, 21:1712-1719. 10.1161/hq1101.098486, 11701455.
19. Werba JP, Tremoli E, Massironi P, Camera M, Cannata A, Alamanni F, Biglioli P, Parolari A. Statins in coronary bypass surgery: rationale and clinical use. Ann Thorac Surg 2003, 76:2132-2140. 10.1016/S0003-4975(03)00820-8, 14667669.
20. Kulik A, Ruel M. Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety. Expert Opin Drug Saf 2009, 8:559-571. 10.1517/14740330903188413, 19673591.
21. Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agrò F, Carassiti M, Covino E. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006, 34:660-667. 10.1097/01.CCM.0000201407.89977.EA, 16505650.
22. Dereli Y, Ege E, Kurban S, Narin C, Sarigul A, Yeniterzi M. Pre-operative atorvastatin therapy to decrease the systemic inflammatory response after coronary artery bypass grafting. J Int Med Res 2008, 36:1248-1254.
23. Lazar HL, Bao Y, Zhang Y, Bernard SA. Pretreatment with statins enhances myocardial protection during coronary revascularization. J Thorac Cardiovasc Surg 2003, 125:1037-1042. 10.1067/mtc.2003.177, 12771876.
24. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2000, 101:207-213.